Published by Benjamin Chiou on 22nd January 2025
(Sharecast News) - Stronger-than-expected sales of cancer drugs helped US healthcare giant Johnson & Johnson beat forecasts with its fourth-quarter results on Wednesday, with guidance for 2025 meeting analysts' expectations.
URL: http://www.digitallook.com/dl/news/story/34829376/...